Axonics Valuation
| 0I3 Stock | EUR 63.50 0.00 0.00% |
At this time, the firm appears to be overvalued. Axonics shows a prevailing Real Value of €52.82 per share. The current price of the firm is €63.5. Our model approximates the value of Axonics from analyzing the firm fundamentals such as Current Valuation of 2.7 B, profit margin of (0.31) %, and Return On Equity of -0.15 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Axonics' price fluctuation is very steady at this time. Calculation of the real value of Axonics is based on 3 months time horizon. Increasing Axonics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Axonics stock is determined by what a typical buyer is willing to pay for full or partial control of Axonics. Since Axonics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Axonics Stock. However, Axonics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 63.5 | Real 52.82 | Hype 63.5 | Naive 63.94 |
The real value of Axonics Stock, also known as its intrinsic value, is the underlying worth of Axonics Company, which is reflected in its stock price. It is based on Axonics' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Axonics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Axonics helps investors to forecast how Axonics stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Axonics more accurately as focusing exclusively on Axonics' fundamentals will not take into account other important factors: Axonics Total Value Analysis
Axonics is presently estimated to have takeover price of 2.7 B with market capitalization of 2.7 B, debt of 10.01 M, and cash on hands of 231.14 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Axonics fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
2.7 B | 2.7 B | 10.01 M | 231.14 M |
Axonics Investor Information
About 99.0% of the company shares are owned by institutions such as pension funds. The company recorded a loss per share of 1.57. Axonics had not issued any dividends in recent years. Based on the key indicators related to Axonics' liquidity, profitability, solvency, and operating efficiency, Axonics is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Axonics Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Axonics has an asset utilization ratio of 32.9 percent. This implies that the Company is making €0.33 for each dollar of assets. An increasing asset utilization means that Axonics is more efficient with each dollar of assets it utilizes for everyday operations.Axonics Ownership Allocation
Axonics retains a total of 49.53 Million outstanding shares. The majority of Axonics outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Axonics to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Axonics. Please pay attention to any change in the institutional holdings of Axonics as this could imply that something significant has changed or is about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.Axonics Profitability Analysis
The company reported the revenue of 180.29 M. Net Loss for the year was (80.07 M) with profit before overhead, payroll, taxes, and interest of 115.72 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Axonics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Axonics and how it compares across the competition.
About Axonics Valuation
The stock valuation mechanism determines Axonics' current worth on a weekly basis. Our valuation model uses a comparative analysis of Axonics. We calculate exposure to Axonics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Axonics's related companies.Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation systems. Axonics, Inc. was incorporated in 2012 and is headquartered in Irvine, California. AXONICS INC operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 416 people.
8 Steps to conduct Axonics' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Axonics' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Axonics' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Axonics' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Axonics' revenue streams: Identify Axonics' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Axonics' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Axonics' growth potential: Evaluate Axonics' management, business model, and growth potential.
- Determine Axonics' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Axonics' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Axonics Stock analysis
When running Axonics' price analysis, check to measure Axonics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Axonics is operating at the current time. Most of Axonics' value examination focuses on studying past and present price action to predict the probability of Axonics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Axonics' price. Additionally, you may evaluate how the addition of Axonics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |